Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) EBIT (2021 - 2023)

Historic EBIT for Biote (BTMD) over the last 3 years, with Q4 2023 value amounting to $5.5 million.

  • Biote's EBIT fell 2457.89% to $5.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $28.7 million, marking a year-over-year increase of 14719.38%. This contributed to the annual value of $31.6 million for FY2024, which is 1030.81% up from last year.
  • Per Biote's latest filing, its EBIT stood at $5.5 million for Q4 2023, which was down 2457.89% from $7.6 million recorded in Q3 2023.
  • Biote's EBIT's 5-year high stood at $10.3 million during Q2 2021, with a 5-year trough of -$85.6 million in Q2 2022.
  • Its 3-year average for EBIT is -$627000.0, with a median of $7.7 million in 2023.
  • In the last 5 years, Biote's EBIT plummeted by 93433.72% in 2022 and then surged by 10895.88% in 2023.
  • Biote's EBIT (Quarter) stood at $5.9 million in 2021, then rose by 23.26% to $7.3 million in 2022, then fell by 24.58% to $5.5 million in 2023.
  • Its EBIT was $5.5 million in Q4 2023, compared to $7.6 million in Q3 2023 and $7.7 million in Q2 2023.